Lecap Asset Management Ltd. Trims Stock Position in Inspire Medical Systems, Inc. (NYSE:INSP)

Lecap Asset Management Ltd. decreased its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 21.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,254 shares of the company's stock after selling 1,412 shares during the period. Lecap Asset Management Ltd.'s holdings in Inspire Medical Systems were worth $974,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Creative Planning lifted its stake in shares of Inspire Medical Systems by 12.4% in the 2nd quarter. Creative Planning now owns 2,575 shares of the company's stock worth $345,000 after purchasing an additional 284 shares during the period. Cetera Investment Advisers raised its position in Inspire Medical Systems by 497.7% in the second quarter. Cetera Investment Advisers now owns 17,512 shares of the company's stock worth $2,344,000 after acquiring an additional 14,582 shares during the period. Handelsbanken Fonder AB boosted its stake in shares of Inspire Medical Systems by 12.0% during the 3rd quarter. Handelsbanken Fonder AB now owns 8,400 shares of the company's stock worth $1,773,000 after acquiring an additional 900 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Inspire Medical Systems by 559.3% during the 3rd quarter. GAMMA Investing LLC now owns 178 shares of the company's stock valued at $38,000 after acquiring an additional 151 shares during the period. Finally, CWM LLC grew its position in shares of Inspire Medical Systems by 550.5% during the 3rd quarter. CWM LLC now owns 8,105 shares of the company's stock valued at $1,711,000 after acquiring an additional 6,859 shares during the period. Hedge funds and other institutional investors own 94.91% of the company's stock.

Inspire Medical Systems Stock Up 1.2 %

INSP stock traded up $2.18 during mid-day trading on Tuesday, hitting $183.17. The company had a trading volume of 1,485,540 shares, compared to its average volume of 623,494. The company has a 50-day moving average price of $189.57 and a 200 day moving average price of $190.98. Inspire Medical Systems, Inc. has a 12-month low of $123.00 and a 12-month high of $257.40. The company has a market capitalization of $5.49 billion, a price-to-earnings ratio of 171.18 and a beta of 1.32.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last posted its earnings results on Monday, February 10th. The company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. As a group, analysts expect that Inspire Medical Systems, Inc. will post 1.33 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on INSP. Robert W. Baird lowered their price objective on Inspire Medical Systems from $252.00 to $248.00 and set an "outperform" rating on the stock in a research report on Tuesday. Royal Bank of Canada reaffirmed an "outperform" rating and set a $260.00 price target on shares of Inspire Medical Systems in a report on Tuesday. Wells Fargo & Company dropped their price target on shares of Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating for the company in a research report on Tuesday. Truist Financial decreased their price objective on shares of Inspire Medical Systems from $250.00 to $235.00 and set a "buy" rating on the stock in a research report on Tuesday. Finally, Morgan Stanley dropped their target price on shares of Inspire Medical Systems from $230.00 to $220.00 and set an "overweight" rating for the company in a report on Tuesday. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Inspire Medical Systems currently has a consensus rating of "Moderate Buy" and an average price target of $228.82.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.